Cellectis S.A. DIO Ratio 2011-2026 | CLLS

Annual DIO Ratio Cellectis S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	23.3	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
23.3	23.3	23.3

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Anika Therapeutics ANIK	247	$ 9.46	1.18 %	$ 139 M	USA
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	239	$ 10.01	-7.66 %	$ 647 M	USA
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
Aclaris Therapeutics ACRS	42.1	$ 2.62	-9.2 %	$ 203 M	USA
Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
Amphastar Pharmaceuticals AMPH	132	$ 26.84	1.42 %	$ 1.3 B	USA
CASI Pharmaceuticals CASI	47.4	$ 0.85	3.22 %	$ 116 M	USA
Catalyst Biosciences CBIO	410	$ 11.08	-0.05 %	$ 729 M	USA
BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
Axon Enterprise AXON	116	$ 593.03	5.25 %	$ 44.9 B	USA
Aytu BioScience AYTU	209	$ 2.9	4.69 %	$ 18.2 M	USA
AstraZeneca PLC AZN	206	$ 91.04	-0.58 %	$ 96.9 B	Britain
Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	125	-	-	$ 546 M	USA
Biogen BIIB	394	$ 174.34	-1.96 %	$ 25.4 B	USA
Abeona Therapeutics ABEO	265	$ 5.23	-1.6 %	$ 112 M	USA